To understand the mechanism of FGFR1 dependency, investigators performed deep genomic characterization of 52 squamous cell lung carcinomas with 8p11-p12-amplification, including 10 tumors obtained from patients who had been treated with FGFR inhibitors.
[Journal Of Clinical Investigation]